Drug name - Nocdurna

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9220747 FERRING PHARMS INC Methods using desmopressin acetate in orodispersible form May, 2023

(7 months from now)

US9504647 FERRING PHARMS INC Pharmaceutical formulations of desmopressin May, 2023

(7 months from now)

US9919025 FERRING PHARMS INC Pharmaceutical formulations of desmopressin May, 2023

(7 months from now)

US10307459 FERRING PHARMS INC Pharmaceutical formulations of desmopressin May, 2023

(7 months from now)

US7947654 FERRING PHARMS INC Pharmaceutical formulations Dec, 2023

(1 year, 2 months from now)

US8802624 FERRING PHARMS INC Methods of treatment using orodispersible desmopressin pharmaceutical formulations Dec, 2023

(1 year, 2 months from now)

US7560429 FERRING PHARMS INC Orodispersible dosage forms of desmopressin acetate Feb, 2024

(1 year, 3 months from now)

US11020448 FERRING PHARMS INC Methods comprising desmopressin May, 2029

(6 years from now)

US10137167 FERRING PHARMS INC Methods comprising desmopressin May, 2029

(6 years from now)

US9974826 FERRING PHARMS INC Methods comprising desmopressin Apr, 2030

(7 years from now)

Drugs and Companies using DESMOPRESSIN ACETATE ingredient

Treatment: Treatment of nocturia due to nocturnal polyuria in adults; Treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration; Treatment of nocturia due to nocturnal polyuria in adults; treatment of nocturia due to nocturnal polyuria in adults, comprising monitoring a patient's serum sodium concentration

Dosage: TABLET;SUBLINGUAL

More Information on Dosage
Strength Dosage Availability
0.0277MG TABLET;SUBLINGUAL Prescription
0.0553MG TABLET;SUBLINGUAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.